Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Dimeticone 100 cSt solution 50% w/w for topical use in the treatment of head lice III JAN / 13
2,4- Dinitrophenol or its salts or derivativesPDL I DEC / 13
DinutuximabPDL I DEC / 18
Dioxaphetyl butyrateN I JUN / 02
Diperodon and its salts except for topical use II SEP / 98
Diphenhydramine and its salts and preparations for parenteral use II SEP / 98
Diphenhydramine and its salts and preparations. except for parenteral or topical use III SEP / 98
Diphenhydramine and its salts and preparations.. for topical use in concentrations of greater than 2% II MAY / 06
Diphenhydramine and its salts and preparations... for topical use in concentrations of 2% or less when sold in containers of greater than 300 mg of diphenhydramine hydrochloride III MAY / 06
Diphenhydramine and its salts and preparations... for topical use in concentrations of 2% or less when sold in containers of 300 mg or less of diphenhydramine hydrochloride U OCT / 09
Diphenidol or its saltsPDL I DEC / 13
DiphenoxylateN I JUN / 02
Diphenylhydantoin (phenytoin) or its saltsPDL I SEP / 98
Diphenylmorpholinoisovaleric acidN I JUN / 02
Diphenylpyraline III SEP / 98
Diphtheria toxoid II DEC / 98
DipipanoneN I JUN / 02
Dipivefrin or its saltsPDL I DEC / 13
Diprophylline or its saltsPDL I DEC / 13
DipyridamolePDL I DEC / 13
DirithromycinPDL

For human use

I DEC / 13
DirlotapidePDL I DEC / 13
Disopyramide or its saltsPDL I DEC / 13
DisulfiramPDL I DEC / 13
Dithranol Anthralin II SEP / 98
Dobutamine or its saltsPDL I DEC / 13
Docetaxel or its derivativesPDL

including but not limited to cabazitaxel

I DEC / 13
Docusate and its salts U
Dolasetron or its saltsPDL I DEC / 13
Dolutegravir or its saltsPDL I DEC / 13
DomperidonePDL I DEC / 13
Donepezil or its saltsPDL I DEC / 13
Dopamine or its saltsPDL

when sold for administration by injection

I DEC / 13
DoravirinePDL I NOV / 18
Dornase alfaPDL I DEC / 13
Dorzolamide or its saltsPDL I DEC / 13
Doxacurium chloridePDL I DEC / 13
DoxapramPDL I DEC / 13
Doxazosin or its saltsPDL I DEC / 13
Doxepin or its saltsPDL I DEC / 13
Doxercalciferol or its derivativesPDL I DEC / 13
Doxorubicin or its saltsPDL I DEC / 13
Doxycycline or its salts or derivativesPDL

including but not limited to doxycycline hyclate, doxycycline monohydrate

I DEC / 13
Doxylamine or its salts

except those sold for nausea and vomiting of pregnancy

III SEP / 98
Doxylamine or its saltsPDL

when sold or recommended for use in the nausea or vomiting of pregnancy

I DEC / 13
Droperidol or its saltsPDL I DEC / 13
DrostanoloneC3 I JUN / 02
DrotebanolN I JUN / 02
DrotrecoginPDL I DEC / 13
DulaglutidePDL I JAN / 16
Duloxetine or its saltsPDL I DEC / 13
DupilumabPDL I MAR / 18
DurvalumabPDL I DEC / 17
DutasteridePDL I DEC / 13
Dyclonine except for topical use on mucous membranes II SEP / 98
Dyclonine and its salts for topical use on mucous membranes, except lozenges III SEP / 98

156 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled